INTRODUCTION

 
Respiratory

Respiratory

Boehringer Ingelheim has emerged as a leader in this disease area, having launched several treatments in a range of respiratory conditions including asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF). COPD is a serious, progressive lung disease that limits airflow in the lungs. COPD is preventable and treatable but not curable and by 2033 it is predicted to be the third leading cause of death worldwide.1 An important goal in the management of COPD is increaseing a patient's ability to live their life to the extent they love to and keep active for longer.

1What is chronic obstructive pulmonary disease (COPD)? World Health Organisation.2013.
http://www.who.int/features/qa/48/en/ (accessed August 2018)

Explore Our Products

Related content

Implications of delayed IPD diagnosis

icoPDF

01/02/2019
Author: Boehringer Ingelheim

Implications of delayed IPD diagnosis

Implications & Importance of diagnosis and treatment in idiopathic pulmonary fibrosis

WR43747-29/01/2020
Production date: Dec 2018